Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-25-000484
Filing Date
2025-05-16
Accepted
2025-05-16 17:21:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4769
  Complete submission text file 0001972362-25-000484.txt   6500
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Subject) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-32295 | Film No.: 25960658
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ADHEREX TECHNOLOGIES INC. 4620 CREEKSTONE DRIVE, SUITE 200 DURHAM NC 27703
Business Address
Raykov Rosty (Reporting) CIK: 0001468316 (see all company filings)

Type: 144